1. Hossain P, Kawar B, El Nahas M. Obesity and Diabetes in the Developing World. A growing challenge. N Engl J Med 2007; 356 (3): 213-215

2. Castelli WP. Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study. Can J Cardiol 1988; Suppl A:5A-10A

3. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347(20): 1557-1565

4. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Despres JP. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Circulation 1997; 95(1): 69-75

5. Martin SS, Qasim AN, Mehta NN, Wolfe M, Terembula K, Schwartz S, Iqbal N, Schutta M, Bagheri R, Reilly MP. Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites. Diabetes 2009; 58(8): 1887-1892

6. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willet WC, Krauss RM. Low density lipoprotein subclass patterns and risk of myocardial infractions. JAMA 1988; 260: 1917-1921

7. Tribble DL, Holl LG, Wood PD, Krauss RM. Variatios in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 1992; 93(3): 189-199

8. Nigon F, Lesnik P, Rouis M, Chapman MJ. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 1991; 32(11): 1741-1753

9. Tanfani F, Galeazzi T, Curatola G, Bertoli E, Ferretti G. Reduced beta-strand content in apoprotein B-100 in smaller and denser low-density lipoprotein subclasses as probed by Fourier-transform infrared spectroscopy. Biochem J 1997; 322 (3): 765-769

10. Hurt E, Bondjers G, Camejo G. Interaction of LDL with human arterial proteoglycans stimulates its uptake by human monocyte-derived macrophages. J Lipid Res 1990; 31(3): 443-454

11. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982; 23(1): 97-104

12. Maruyama C, Imamura K, Teramoto T. Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia. J Atheroscler Thromb 2003; 10(3): 186-191

13. Gaziano JM, Hennekens CH, O’Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high density lipoprotein, and risk of myocardial infarction. Circulation 1997; 96(8): 2520–2525

14. Giannini C, Santoro N, Caprio S, Kim G, Lartaud D, Shaw M, Pierpont B, Weiss R. The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes Care 2011; 34(8): 1869-1874

15. Kang HT, Yoon JH, Kim JY, Ahn SK, Linton JA, Koh SB, Kim JK. The association between the ratio of triglyceride to HDL-C and insulin resistance according to waist circumference in a rural Korean population. Nutr Metab Cardiovasc Dis 2012; 22(12): 1054-1060

16. Wakabayashi I. Influence of age and gender on triglycerides-to-HDL-cholesterol ratio (TG/HDL ratio) and its association with adiposity index. Arch Gerontol Geriatr 2012; 55(3): 729-734

17. Rocchini AP, Katch V, Kveselis D, Moorehead C, Martin M, Lampman R, Gregory M. Insulin and renal sodium retention in obese adolescents. Hypertension 1989; 14(4): 367-374

18. Menegon LF , Zaparolli A, Boer PA, de Almeida AR, Gontijo JA. Long-term effects of intracerebroventricular insulin microinjection on renal sodium handling and arterial blood pressure in rats. Brain Res Bull 2008; 76(4): 344- 348

19. Hernández J, Alfieri A, Hoffmann I, Ramirez A. Factores de riesgo del Síndrome Metabólico asociados al incremento de la natriurésis. Rev Latinoam Hipertens 2012; 7(3): 53-57

20. Hoffmann IS, Cubeddu LX. Salt and the metabolic syndrome. Nutr Metab Cardiovasc Dis 2009; 19(2): 123-128

21. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003; 88(6): 2404-2411

22. Huang Y, Van Horn L, Tinker LF, Neuhouser ML , Carbone L, Mossavar-Rahmani Y, Thomas F, Prentice RL. Measurement error corrected sodium and potassium intake estimation using 24-hour urinary excretion. Hypertension 2014; 63(2): 238-244

23. Fulgoni VL, Agarwal S, Spence L, Samuel P. Sodium intake in US ethnic subgroups and potential impact of a new sodium reduction technology: NHANES Dietary Modeling. Nutr J 2014; 13(1): 120

24. Rodriguez-Iturbe B, Romero F, Johnson RJ. Pathophysiological mechanisms of salt-dependent hypertension. Am J Kidney Dis 2007; 50(4): 655-672

25. Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. Effect of lower sodium intake on health: systematic review and meta-analyses.Brit Met J 2013; 346: 326

26. Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. Brit Med J 2009; 339: b4567

27. Vega GL, Barlow CE, Grundy SM, Leonard D, DeFina LF. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men. J Investig Med. 2014 Feb;62(2):345-349

28. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D’Agostino RBSr, O’Donnell CJ. Abdominal Visceral and Subcutaneous Adipose Tissue Compartments. Association With Metabolic Risk Factors in the Framingham Heart Study. Circulation 2007; 116(1): 39-48

29. Schäfer K, Konstantinides SV. Update on the cardiovascular risk in obesity: endocrine and paracrine role of the adipose tissue Hellenic J Cardiol 2011; 52(4): 327-336

30. Wakabayashi I, Daimon T. Age-Dependent Decline of Association Between Obesity and Hyperglycemia in Men and Women. Diabetes Care 2012; 35(1): 175–177

31. Wang Z, Hoy WE. Age-dependent decline of association between obesity and coronary heart disease: a cohort study in a remote Australian Aboriginal community. BMJ Open. 2013; 3(11): e004042

32. Winter JE, MacInnis RJ, Wattanapenpaiboon N, Nowson CA. BMI and all-cause mortality in older adults: a meta-analysis. Am J Clin Nutr 2014; 99(4): 875-890

33. Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR, Williams GH, Adler GK. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation 2008 ; 117(17): 2253–2261

34. Baudrand R, Lian CG, Lian BQ, Ricchiuti V, Yao TM, Li J, Williams GH, Adler GK. Long-term dietary sodium restriction increases adiponectin expression and ameliorates the proinflammatory adipokine profile in obesity. Nutr Metab Cardiovasc Dis 2014; 24(1): 34-41

35. Tao C, Sifuentes A, Holland WL. Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic β cells and adipocytes. Best Pract Res Clin Endocrinol Metab 2014; 28(1): 43-58